Allscripts Beats Estimates (MDRX)

Allscripts Healthcare Solutions, Inc. MDRX reports Q3 earnings of $0.19 versus consensus of $0.18. Allscripts Healthcare Solutions, Inc. reports revenues of $242.4 million versus consensus of $192.50 million. "I am pleased with our strong operating performance during a quarter that included the successful merger with Eclipsys and solid progress on integration," said Glen Tullman, Chief Executive Officer of Allscripts. "We are also excited by the industry's positive reaction to the merger. Clients and prospects tell us they appreciate having a new choice in the market, whether for a fully integrated solution that connects ambulatory practices to hospitals or for a best-of-breed approach that allows our clients to build on what they have. Our goal is to create a new operating model for healthcare--a connected community of health--and our merger moves our clients and their patients one step closer to that goal." The company sees FY 2010 adjusted EPS in the range of $0.73-0.74 and FY 2011 adjusted EPS of $0.85-0.89. Shares of MDRX are lower in the after-hours by 1.86%.